BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1490367)

  • 21. Oncogenes, normal cell growth, and connective tissue disease.
    Sibbitt WL
    Annu Rev Med; 1988; 39():123-33. PubMed ID: 3285766
    [No Abstract]   [Full Text] [Related]  

  • 22. The myb oncogene.
    Shen-Ong GL
    Biochim Biophys Acta; 1990 Jun; 1032(1):39-52. PubMed ID: 2194567
    [No Abstract]   [Full Text] [Related]  

  • 23. Some characteristics of neoplastic cell transformation in transgenic mice.
    Shvemberger IN; Ermilov AN
    Int Rev Cytol; 1996; 164():37-90. PubMed ID: 8575893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transgenic mice for analysis of neoplasm transformation processes of T and B lymphocytes].
    Kobzdej M; StrzadaƂa L
    Postepy Hig Med Dosw; 1996; 50(2):113-29. PubMed ID: 8848421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of lymphocyte survival by the bcl-2 gene family.
    Cory S
    Annu Rev Immunol; 1995; 13():513-43. PubMed ID: 7612233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oncogenes in human hematopoietic neoplasia].
    Larsen C
    Pathol Biol (Paris); 1992 Nov; 39(9):867-8. PubMed ID: 1538913
    [No Abstract]   [Full Text] [Related]  

  • 27. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death.
    Korsmeyer SJ; Shutter JR; Veis DJ; Merry DE; Oltvai ZN
    Semin Cancer Biol; 1993 Dec; 4(6):327-32. PubMed ID: 8142617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth factor, viruses, and oncogenes in human lymphoid neoplasia.
    Sharma S; Mehta SR; Ford RJ
    Lymphokine Res; 1987; 6(3):245-65. PubMed ID: 3306177
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential expression of myc-family genes during development: normal and deregulated N-myc expression in transgenic mice.
    Dildrop R; Zimmerman K; DePinho RA; Yancopoulos GD; Tesfaye A; Alt FW
    Curr Top Microbiol Immunol; 1988; 141():100-9. PubMed ID: 3215042
    [No Abstract]   [Full Text] [Related]  

  • 30. [Neoplastic transformation of the pluripotential stem cell. I. Possible molecular mechanisms of neoplastic transformation].
    Rupniewska ZM
    Acta Haematol Pol; 1985; 16(1-2):90-101. PubMed ID: 3914172
    [No Abstract]   [Full Text] [Related]  

  • 31. Oncogenes and autoimmunity.
    Boumpas DT; Mark GE; Tsokos GC
    Anticancer Res; 1986; 6(3 Pt B):491-7. PubMed ID: 3527035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogene.
    Das UN
    J Assoc Physicians India; 1992 Apr; 40(4):258-61. PubMed ID: 1280637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notes on advances in developmental biology, cell adhesion, oncogenes, metastasis, differentiation markers in lymphoid tumors.
    Berneman ZN
    Leuk Res; 1986; 10(3):251-6. PubMed ID: 3485225
    [No Abstract]   [Full Text] [Related]  

  • 34. The myc oncogene: its role in transformation and differentiation.
    Cole MD
    Annu Rev Genet; 1986; 20():361-84. PubMed ID: 3028245
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells.
    Graninger WB; Seto M; Boutain B; Goldman P; Korsmeyer SJ
    J Clin Invest; 1987 Nov; 80(5):1512-5. PubMed ID: 3500184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of immunoglobulin genes in lymphoid oncogenesis.
    Adams JM
    Bioessays; 1986 Jun; 4(6):267-9. PubMed ID: 3790127
    [No Abstract]   [Full Text] [Related]  

  • 37. Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector.
    Adams JM; Harris AW; Strasser A; Ogilvy S; Cory S
    Oncogene; 1999 Sep; 18(38):5268-77. PubMed ID: 10498879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of thymic selection in the development of thymic lymphomas in TCR transgenic mice.
    Strzadala L; Miazek A; Matuszyk J; Kisielow P
    Int Immunol; 1997 Jan; 9(1):127-38. PubMed ID: 9043954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The transgenic window on lymphoid malignancy.
    Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
    Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
    Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
    Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.